With the speed Ariad is signing up Sites for the Ponatinib Trial, and based upon listening carefully to the words HB used in the last few conferences, I am going out on a limb and predicting that we achieve full enrollment by no later than September 30th. If that happens, it will be a full threee months ahead of the original schedule.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.